Med News category - Thailand Medical News

Multiple Sclerosis: Novartis’s New Drug Ofatumumab Shows Ability To Prevent Multiple Sclerosis Relapses In Phase 3 Trial

Source: Multiple Sclerosis: Aug 06, 2020 4 years ago

Multiple Sclerosis: A recently completed phase 3, multicenter clinical trial has found that an immune-modulating drug can silence inflammatory disease activity in a large majority of patients with relapsing multiple sclerosis (RMS), the most common form of the illness, in which symptoms wax and wane. Multiple Sclerosis or MS is an autoimmune disease in which the body's immu...

Head Lice: University Of Melbourne’s New Head Lice Treatment, Xeglyze Gets US FDA Approval

Source: Head Lice Aug 04, 2020 4 years ago

Head Lice: A novel prescription head lice treatment, developed by University of Melbourne Associate Professor Dr Vern Bowles, has been given Food and Drug Administration (FDA) approval, allowing it to be sold in the U.S. The new treatment, Xeglyze, was developed by Hatchtech, an Australian pharmaceutical company and will be commercialised by Dr. Reddy's Laboratories. Hugh Alsop, ...

Sports Medicine: Norwegian Study Reveals That Beta2-Agonists, An Asthma Drug Has Ergogenic Properties And Can Boost Sprint And Strength In Athletes

Source: Sports Medicine Aug 04, 2020 4 years ago

Sports Medicine: Researchers from Western Norway University of Applied Sciences and the Norwegian University of Sport and Physical Education have discovered that a type of asthma drug, known as ß2-agonists, can boost sprint and strength performance in athletes who don't have the respiratory condition. Their research findings have been published in the British Journal of Spo...

MEDICINE ALERT! Study Led By Penn State Shows That L-Type Calcium Channel Blockers (LCCBs) Used To Treat Hypertension May Actually Harm The Heart

Source: Medicine Alert Jul 24, 2020 4 years ago

Medicine Alert: Pennsylvania State University researchers along with scientists from La Jolla Institute for Immunology-California and Weill Cornell Medicine-Qatar, have found that in rats and human cells in vitro, LCCBs cause changes in blood vessels known as vascular remodeling that reduce blood flow and increase pressure and could potentially lead to heart failure. The study finding...

MUST READ! COVID-19 Warnings: High Blood Pressure Drug Captopril Associated With Pulmonary Adverse Reactions In COVID-19 Patients With Diabetes

Source: COVID-19 Warnings- Captopril Jul 07, 2020 4 years ago

COVID-19 Warnings: A US based study involving researchers from University of Missouri Kansas City School of Pharmacy, Kansas State University and North Carolina State University has found that the high blood pressure drug Captopril to be associated with a higher rate of pulmonary adverse reactions in patients with diabetes than that of other ACE inhibitors or angiotensin receptor blockers (ARBs). ...

US FDA Approves First Oral Form Of Octreotide For Treatment Of Acromegaly

Source: Octreotide and Acromegaly Jun 27, 2020 4 years ago

Octreotide and Acromegaly: The American Food and drug administration has approved the first and only oral form of somatostatin analog octreotide ( tradename: Mycapssa) as a long-term maintenance therapy for individuals with acromegaly. The drug Octreotide by Chiasma pharmaceuticals is the first product approved by the FDA using Chiasma's Transient Permeability Enhancer (TPE) tec...

Multiple Sclerosis: Study Shows Most Drugs Prescribed For Treatment Of Multiple Sclerosis-Related Cognitive Impairment Do Not Work!

Source: Multiple Sclerosis Jun 18, 2020 4 years ago

Multiple Sclerosis: Medical researchers from the Kessler Foundation recently conducted a comprehensive review of pharmacologic agents used in the treatment of multiple sclerosis, seeking evidence for efficacy for the cognitive dysfunction experienced by more than half of affected individuals and found that most of the prescribed drugs do not work. The research findings were published in the...

Vildagliptin Just As Efficient As Metformin In Controlling Blood Sugar For Diabetics According To Indian Study

Source: Vildagliptin Versus Metformin Jun 17, 2020 4 years ago

Vildagliptin an oral anti-hyperglycemic agent that goes by the trade name Galvus showed similar protective effects as metformin on the beta-cell function, reduced insulin resistance, and blood sugar levels in newly diagnosed Asian Indians with type 2 diabetes (T2D), according to a recent study. The research trial further found that there was an improved insulin sensitivity in patients treated wi...

Pharmaceuticals: US FDA Grants Approval For Nivolumab As Treatment Drug For Esophageal Squamous Cell Carcinoma

Source: Pharmaceuticals Jun 12, 2020 4 years ago

Pharmaceuticals: The US Food and Drug Administration has approved nivolumab (OPDIVO) by Bristol-Myers Squibb for patients with unresectable advanced, recurrent or metastatic esophageal squamous cell carcinoma (ESCC) after prior fluoropyrimidine- and platinum-based chemotherapy. Proof for efficacy was investigated in ATTRACTION-3 (NCT02569242), a multicenter, randomized (1:1), active-controlled,...

BREAKING!! Metformin: US FDA Issues Warning That Carcinogenic Contaminants Found In Several Brands Of The Diabetes Drug And Starts Recall

Source: Metformin and Diabetes May 30, 2020 4 years ago

Metformin: The US FDA has issued warnings that many brands and versions of the drug Metformin that is used by diabetics in the US and around the world have been found to be contaminated with a carcinogenic compound called N-Nitrosodimethylamine. The U.S. health regulators have started telling five drugmakers to recall their versions of a widely used diabetes medication after laboratory te...

Janssen’s Esketamine Nasal Spray Which Is Similar To the Illegal Opioid Ketamine Gets Approved in the EU

Source: Thailand Medical News Jan 03, 2020 4 years ago

In a latest development, the European Commission (EC) has approved Johnson & Johnson subsidiary Janssen’s Spravato (esketamine) nasal spray for treatment-resistant major depressive disorder. Spravato or Esketamine is an antagonist of the N-methyl-D-aspartate (NMDA) glutamate receptor and is similar in composition to illegal drug ketamine; Janssen has a risk management plan related to ...

Clinical Trials Shows That Entrectinib Performs Well In ROS1 And NTRK Gene Driven Non-Small Cell Lung Cancers

Source: Thailand Medical News Dec 14, 2019 4 years ago

Combined analysis of three phase 1 and 2 clinical trials published online ahead of print in the journal Lancet Oncology show that the drug entrectinib is effective and well-tolerated against advanced ROS1 and NTRK fusion-positive non-small cell lung cancers (NSCLC). Results of the trials STARTRK-1 (NCT02097810), STARTRK-2 (NCT02568267), and ALKA, show 77 percent response rate to entrectinib in 53 ...

Cinnarizine And Sodium Valproate For Pediatric Migraine Prevention

Source: Thailand Medical News Dec 11, 2019 4 years ago

A new research by pediatrics and migraine specialists from the University of Medical Sciences, Tehran show that Cinnarizine and Sodium Valproate are effective as the preventive agents of pediatric migraine in young children and teenagers. The study article entitled "Cinnarizine and sodium valproate as the preventive agents of pediatric migraine: A randomized double-blind placebo-controlled t...

US FDA Grants Imfinzi Priority Review For Treatment Of Extensive-Stage Small Cell Lung Cancer

Source: Thailand Medical News Dec 02, 2019 4 years ago

Pharma Conglomerate, AstraZeneca announced that the US Food and Drug Administration (FDA) has accepted a supplemental Biologics License Application (sBLA) and granted Priority Review for Imfinzi (durvalumab) for the treatment of patients with previously untreated extensive-stage small cell lung cancer (SCLC). Small Cell Lung Cancer is an aggressive, fast-growing form of lung cancer that r...

US FDA Approves New Dementia Treatment Patch, SID710

Source: Thailand Medical News Nov 29, 2019 4 years ago

The US FDA (Food and Drug Administration) has approved South Korean company SK Chemicals’ patch-type Alzheimer’s drug, SID710. The drug which has already secured approval in the European Union in 2013, is the generic version of Novartis’ Exelon Patch for the treatment of dementia symptoms associated with Alzheimer’s disease. The approval marks the first time...

Acalabrutinib (Calquence) Approved By US FDA For Chronic Lymphocytic Leukemia

Source: Thailand Medical News Nov 22, 2019 4 years ago

Thailand Pharma News The US FDA has granted supplemental approval to acalabrutinib (Calquence, AstraZeneca) for the treatment of adults with chronic lymphocytic leukemia (CLL) or small lymphocytic leukemia (SLL).1 The Project Orbis, a collaboration between the United States, Australia, and Canada, provides a framework for concurrent submission and review of oncology pharmaceutical ap...

US FDA Approves New Antibacterial Drug Fetroja (cefiderocol) To Treat Complicated Urinary Tract Infections

Source: Thailand Medical News Nov 20, 2019 4 years ago

The US FDA (Food and Drug Administration ) has approved Fetroja (cefiderocol), an antibacterial drug for treatment of patients 18 years of age or older with complicated urinary tract infections (cUTI), including kidney infections caused by susceptible Gram-negative microorganisms, who have limited or no alternative treatment options. Dr John Farley, acting director of the Office of Infecti...

Novartis‘s Adakveo Approved By US FDA To Treat Sickle Cell Disease

Source: Thailand Medical News Nov 16, 2019 5 years ago

The US Food and Drug Administration approved Novartis AG's Adakveo (crizanlizumab) as new medicine that can help reduce extremely painful sickle cell disease flare-ups for patients 16 and older. The monthly infusion, which halves occurrences of sickle cell pain episodes, will carry a list price of roughly US$82,000 to US$114,000 per year, depending on dosing. Unfortunately, sickle cell dise...

Key Drug Black Box Warnings Every Doctor Should Know

Source: Thailand Medical News Nov 10, 2019 5 years ago

The US FDA approved a record-breaking 59 novel drugs in 2018 for a range of diseases, bringing hope to scores of health sufferers around the world. This number was a more than twofold increase from a decade prior, which saw only 24 new drug approvals. And while this rise in the production and dissemination of new biological agents and products is good news for the advancement of global h...

US FDA Approves Reblozyl (Luspatercept-aamt) To Rare Blood Disorder: Beta Thalassemia

Source: Thailand Medical News Nov 09, 2019 5 years ago

The U.S. Food and Drug Administration has granted approval for Reblozyl (luspatercept-aamt) to be used for the treatment of anemia (lack of red blood cells) in adult patients with beta thalassemia who require regular red blood cell (RBC) transfusions. Dr Richard Pazdur, M.D., director of the US FDA's Oncology Center of Excellence and acting director of the Office of Oncologic Diseases in th...

Clinical Trial Shows Dupilumab (Dupixent) Helps Uncontrolled Asthma

Source: Thailand Medical News Oct 26, 2019 5 years ago

New findings from the LIBERTY ASTHMA QUEST trial show that add-on dupilumab (Dupixent) showed symptomatic benefit for patients with both early-onset and later-onset uncontrolled asthma. In trial data published in the Chest Journal, the interleukin 4 and 13 (IL-4; IL-13) targeting monoclonal antibody showed an associated reduction of severe exacerbations and improved lung function in patien...

Canagliflozin (Invokana) Approved To Treat Diabetic Kidney Disease

Source: Thailand Medical News Oct 25, 2019 5 years ago

The US FDA has approved a new indication for the SGLT2 inhibitor canagliflozin made by Janssen Pharmaceuticals to reduce the risk for end-stage renal disease, worsening of kidney function, cardiovascular death and hospitalization for heart failure among adults with type 2 diabetes and diabetic kidney disease. Type 2 diabetes is the leading cause of kidney disease in the world, and the fifth fastes...

Trikafta From Vertex Pharmaceuticals Approved By US FDA As New Treatment Drug For Cystic Fibrosis

Source: Thailand Medical News Oct 23, 2019 5 years ago

Trikafta (elexacaftor/ivacaftor/tezacaftor) from Vertex Pharmaceuticals is the first triple combination therapy to be approved by the US FDA and made available to treat patients with the most common cystic fibrosis mutation. Its list price is US$350,000 a year, same as one of the maker's earlier treatments for the genetic disease. Trikafta has been approved for patients aged 12 an...

Cheap Tranexamic Acid Meds Can Saves Millions Due To Head Injuries

Source: Thailand Medical News Oct 22, 2019 5 years ago

A study by the London School of Hygiene & Tropical Medicine has shown that Tranexamic Acid, a low cost and widely available drug could reduce deaths in traumatic brain injury patients by as much as 20%, depending on the severity of injury. The findings were published in the The Lancet. The researchers say that tranexamic acid, (TXA), a drug that prevents bleeding into the brain by inhibit...

Genentech’s Flu Drug, Xofluza Obtains US FDA Approval

Source: Thailand Medical News Oct 20, 2019 5 years ago

A new flu drug by Genentech, Xofluza (baloxavir marboxil) has been granted US Food and Drug Administration (FDA) approval for a supplemental New Drug Application (NDA). The US FDA approval has been given for the indication of acute, uncomplicated influenza, or flu, in individuals aged 12 and older who have been symptomatic for no more than 48 hours and who are at high risk of developing flu-rela...

Warning: Zantac (Ranitidine) Disintegrates Into A Carcinogenic Compound

Source: Thailand Medical News Oct 14, 2019 5 years ago

New study shows that ranitidine is an unstable molecule that breaks down under different conditions into the carcinogen N-nitrosodimethylamine (NDMA). Online pharmacy Valisure is claiming that the Zantac is carcinogenic with N-nitrosodimethylamine (NDMA); that is a byproduct of the breakdown of the ranitidine molecule. The company, which performs its own testing on drugs it carries,...

Nilotinib Can Be Repurposed As A Drug For Treating Pediatric Brain Cancer

Source: Thailand Medical News Sep 23, 2019 5 years ago

Researchers at Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego have discovered that Nilotinib (Tasigna), a drug used to treat chronic myeloid leukemia (CML) appears to be more effective at stopping a type of brain cancer called medulloblastoma in animal models than existing treatments for the deadly pediatric brain tumor. Nilotinib is a type...

US FDA Approves Supplemental NDAs For Delstrigo And Pifeltro For HIV Treatment

Source: Thailand Medical News Sep 21, 2019 5 years ago

The US FDA has approved supplemental new drug applications (NDAs) to expand the use of the drugs Pifeltro and Delstrigo as inclusions in the treatment of patients who are virologically suppressed on a stable ART regimen with no previous history of treatment failure. The approvals provide HIV patients with a wider option of drugs for their ART regiments. The new approval is for adults curr...

Study Shows Ticagrelor Reduced Heart Attacks And Strokes In Diabetics

Source: Thailand Medical News Sep 02, 2019 5 years ago

Researchers from Brigham Hospital and Greater Paris University Hospitals presented the results from The Effect of Ticagrelor on Health Outcomes in Diabetes Mellitus Patients Intervention Study (THEMIS), during the current European Society of Cardiology Congress 2019.The clinical trial evaluated whether adding ticagrelor to aspirin improves outcomes for patients with stable coronary art...

Pretomanid Approved By US FDA For Newly Emerging Extensively Drug Resistant Tuberculosis

Source: Thailand Medical News Aug 16, 2019 5 years ago

The US FDA announced this week the approval of pretomanid tablets as part of a 3 drug combo protocol for the treatment regimen for the most deadly strain of tuberculosis which is fast spreading globally with increasing occurrence rates. Pretomanid (PA-824) tablets were approved to be used as part of a three drug combination protocol along with bedaquiline and linezolid in patients with extensive ...

Self-Administration Nucala For Eosinophilic Asthma Gets EU Approval

Source: Thailand Medical News Aug 03, 2019 5 years ago

The European Commission on Ist Of August had granted marketing authorisation for two new methods of administering Nucala (mepolizumab): a pre-filled pen and a pre-filled safety syringe. This is the only monthly dose anti-IL5 biologic approved in Europe that patients with severe eosinophilic asthma can self-after getting it prescribed by a pulmonologists. The original lyophilised version remains av...

US FDA Approves Selinexor (Xpovio) For Treatment of Relapsed Or Refractory Multiple Myeloma.

Source: Thailand Medical News Jul 04, 2019 5 years ago

The US FDA has approved a new drug, Selinexor to treat patients with relapsed or refractory multiple myeloma, overruling a panel of external cancer experts who expressed concerns about its toxicity. The FDA approval was under an accelerated, or conditional, approval based on a single-arm clinical trial showing a 25% tumor response rate. The patients enrolled in the clinical trial...

Vascepa Set To Steal Market Share From Statins.

Source: Thailand Medical News Jun 01, 2019 5 years ago

Vascepa ( Icosapent Ethyl) by Amarin Group Of Companies, (New Jersey, US) is the only EPA prescription Omega-3 clinically proven to lower very high triglycerides in adults by 33%, without raising bad cholesterol (LDL-C). Unlike VASCEPA, common Omega Oil and fish oil supplements are not pure EPA and most also contain DHA which can raise bad cholesterol. The produc...

Piqray (Alpelisib),The First PI3K inhibitor Approved By US FDA For Breast Cancer

Source: US FDA May 29, 2019 5 years ago

The U.S. FDA has approved Piqray (alpelisib) tablets, to be used in combination with the approved endocrine therapy fulvestrant, to treat postmenopausal women, and men, with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, PIK3CA-mutated, advanced or metastatic breast cancer (only as detected by an FDA-approved test) following progression on or after an end...

Pzifer’s Fragmin Drug Gets US FDA’s Approval For Treatment Of Pediatric Venous Thromboembolism (VTE)

Source: Thailand Medical News May 19, 2019 5 years ago

US FDA has approved the Dalteparin Sodium, (Fragmin) which is a low molecular weight heparin(LMWH) for the treatment of of symptomatic venous thromboembolism (VTE) in pediatric patients 1 month of age and older. Venous thromboembolism (VTE) is a condition in which a blood clot forms most often in the deep veins of the leg, groin or arm (known as deep vein thrombosis, DVT) ...

FDA approves Benlysta for pediatric patients with lupus

Source: US FDA May 01, 2019 5 years ago

The U.S. Food and Drug Administration approved Benlysta (belimumab) intravenous (IV) infusion for treatment of children with systemic lupus erythematosus (SLE) - often referred to as simply "lupus" - a serious chronic disease that causes inflammation and damage to various body tissues and organs. This is the first time that the FDA has approved a treatment for pediatric patients with SLE...

Anti-skin cancer drug approved in EU

Source: Sanofi Apr 27, 2019 5 years ago

French pharmaceutical giant Sanofi on Friday said the European Medicines Agency had conditionally approved its anti-cancer drug Libtayo, the first drug of its kind to be authorised for use in the EU. The drug, also known as CEMIPLIMAB-RWLC is used for for treatment of Advanced Cutaneous Squamous Cell Carcinoma The tumour-reducing drug is aimed at patients with the second most common form of ski...

Study shows Metformin help patients maintain weight loss long-term

Source: American College of Physicians Apr 24, 2019 5 years ago

In the Diabetes Prevention Program (DPP) clinical trial and its long-term follow-up study, among the persons who lost at least 5 percent of their body weight during the first year, long-term maintenance of weight loss was more likely if they had been assigned to treatment with metformin than with placebo or lifestyle intervention. Being older and losing a greater amount of weight in the first year...

Drug, Canagliflozin reduces risk of kidney failure in people with diabetes

Source: Stanford Medicine Apr 16, 2019 5 years ago

A new landmark clinical trial shows that a drug lowers the risk of kidney failure by a third in people with Type 2 diabetes and kidney disease. "For the first time in 18 years, we have a therapy for patients with Type 2 diabetes and chronic kidney disease that decreases kidney failure," said Kenneth Mahaffey, MD, professor of medicine at the Stanford University School of Medicine and co...

US FDA approves Cimzia injections for patients with a type of inflammatory arthritis

Source: US FDA Apr 02, 2019 5 years ago

The U.S. Food and Drug Administration has approved Cimzia (certolizumab pegol) injection for treatment of adults with a certain type of inflammatory arthritis called non-radiographic axial spondyloarthritis (nr-axSpA), with objective signs of inflammation. This is the first time that the FDA has approved a treatment for nr-axSpA. "Today's approval of Cimzia fulfills an unmet need for pa...

Cancer prevention drug Eflornithine, also disables H. pylori bacterium

Source: Vanderbilt University Medical Center Mar 29, 2019 5 years ago

A medicine currently being tested as a chemoprevention agent for multiple types of cancer has more than one trick in its bag when it comes to preventing stomach cancer, Vanderbilt researchers have discovered. The investigators found that in addition to its known ability to block the production of cell growth compounds, the drug DFMO (difluoromethylornithine, known also as Eflornithine and...

Atorvastatin, Drug used to control cholesterol found effective against cancer-associated cachexia

Source: University Of Massachusetts Mar 21, 2019 5 years ago

Brazilian researchers have discovered that a drug regularly prescribed to control cholesterol can also be used to treat cachexia, or wasting syndrome, a condition characterized by rapid weight loss and muscle atrophy associated with extreme physical weakness. This condition is common among patients with chronic diseases such as cancer, heart failure and AIDS. "Our goal is to underst...

Olaparib (Lynparza) successful in pancreatic cancer phase 3 trial

Source: AstraZeneca Mar 03, 2019 5 years ago

AstraZeneca and MSD have announced positive results from the Phase III POLO trial, in which there was a statistically significant and clinically meaningful improvement in progression-free survival (PFS) with Lynparza (olaparib) for pancreatic cancer, making it the first PARP inhibitor to demonstrate benefit in the disease. The drug is a first-in-class PARP inhibitor, and the first targeted treat...

Latest study links Celebrex to Heart Valve Calcification after earlier research declared drug safe

Source: Vanderbilt University Feb 24, 2019 5 years ago

A well-known, four-year study found popular arthritis drug Celebrex no more dangerous for the heart than older drugs in its same classification - commonly called NSAIDs. Now, a big-data analysis of patient records at Vanderbilt University has found a link specifically between Celebrex and heart valve calcification. W. David Merryman, professor of biomedical engineering, and Ph.D. student Megan B...

Antidepressant drug, Fluvoxamine stops deadly Sepsis

Source: University of Virginia Feb 15, 2019 5 years ago

An antidepressant drug used to treat obsessive-compulsive disorder could save people from deadly sepsis, new research from the University of Virginia School of Medicine suggests. Sepsis is a significant cause of death around the world. The federal Centers for Disease Control and Infection calls it "the body's extreme response to an infection." Essentially, the body's immune re...

Breaking News: High Drug Concentrations Lead to Voluntary Recall of Infants’ Ibuprofen worldwide

Thailand Medical News Feb 05, 2019 5 years ago

Tris Pharma Inc. voluntarily recalled three lots of Infants’ Ibuprofen Concentrated Oral Suspension, USP 50 mg per 1.25 mL, to the retail level. The recalled lots of the product have been found to have potentially higher concentrations of ibuprofen than normal. Images of packagings of recalled products “There is a remote possibility that infants, who may be more susceptible to...

Hetero Pharmaceuticals launches generic lapatinib in India

Source: Thailand Medical News Feb 03, 2019 5 years ago

Hetero, one of India’s leading generic pharmaceutical companies and world’s largest producer of anti-retroviral drugs, announces the launch of generic version of lapatinib (250 mg) tablets in India. The product is marketed and distributed under the brand name ‘Hertab’ by Hetero Healthcare Ltd. It is made available in two SKUs, each consisting of 30 tablets and 150 tablets. ...

Dsuvia which is 10 times stronger than Fentanyl and 1000 times stronger than Morphine, approved by US FDA and EU.

Thailand Medical News Jan 19, 2019 5 years ago

The US FDA and EU has approved a new sublingual formulation of sufentanil, Dsuvia, for the management of acute pain in adults in medically supervised healthcare settings, such as hospitals, surgical centers, and emergency departments. The drug is supplied in a 30 microgram tablet in a single-dose, prefilled applicator for administration by a healthcare professional, and it will not be availa...

FDA approves Ultomiris (Ravulizumab) as new treatment for adult patients with PNH.

Source: US FDA Jan 13, 2019 5 years ago

The U.S. Food and Drug Administration today approved Ultomiris (ravulizumab) injection for the treatment of adult patients with paroxysmal nocturnal hemoglobinuria (PNH), a rare and life-threatening blood disease. “The approval of Ultomiris will change the way that patients with PNH are treated,” said Richard Pazdur, M.D., director of the FDA’s Oncology Center of Excellence and...

Rituximab (Rituxan) May Delay Secondary Progressive Multiple Sclerosis.

Source: National Multiple Sclerosis Society Jan 10, 2019 5 years ago

An immune system drug may help prevent or slow complications in a type of multiple sclerosis known as secondary progressive MS, a new study finds. The medication is called rituximab (Rituxan). It's used to treat a number of conditions, including certain blood cell cancers and the autoimmune condition rheumatoid arthritis. The new Swiss study found that MS patients taking the drug reported ...

Painful Intercourse in Women Improved with Gabapentin, an oral nerve pain drug

Source: Rutgers Robert Wood Johnson Medical School. Jan 08, 2019 5 years ago

Women with chronic pain or discomfort around the vulva showed improved sexual function with an oral nerve pain medication used to treat pain caused by a previous herpes infection as well as fibromyalgia, according to a Rutgers study. The study, which was the first to analyze sexual function in women with vulva pain treated with Gabapentin, appeared in the American Journal of Obstetri...

Zoliflodacin, A Novel antibiotic shows promise in treatment of Gonorrhea

Source: Louisiana State University Health Sciences Center Jan 01, 2019 5 years ago

An investigational oral antibiotic called zoliflodacin was well-tolerated and successfully cured most cases of uncomplicated gonorrhea when tested in a Phase 2 multicenter clinical trial, according to findings published in the New England Journal of Medicine. The National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. National Institutes of Health, sponsored the ...

Antiepileptic Drugs (AEDs) linked to rare serious skin reactions.

Source: University of Rhode Island College of Pharmacy (Kingston) Nov 18, 2018 6 years ago

Antiepileptic drugs were found to be linked with almost ninefold increased odds for two adverse skin reactions, Steven‐Johnson syndrome and toxic epidermal necrolysis, compared with non-AED medication classes in an analysis of adverse-event data from the Food and Drug Administration Adverse Event Reporting System. Researchers at the University of Rhode Island College of Pharmacy in Kingston, wh...

US FDA Approves Cemiplimab for Advanced cSCC

Source: US FDA Nov 17, 2018 6 years ago

The US Food and Drug Administration has approved cemiplimab (Libtayo) for use in patients with locally advanced or metastatic cutaneous squamous cell carcinoma (cSCC). This agent is the first to be approved for advanced cSCC and is intended for those who are not eligible for curative surgery or radiation. Researchers reported on the efficacy of cemiplimab in expansion cohorts of a phase I...

Xarelto or Rivaroxaban Reduces Thromboembolic Risk in HF Patients

Source: American Heart Association Nov 14, 2018 6 years ago

Low-dose rivaroxaban (Xarelto) added to antiplatelet therapy was associated with reduced risk of thromboembolic events in heart failure patients, researchers reported here. In post hoc analysis of the COMMANDER HF trial, rivaroxaban (2.5 mg twice daily) led to a lower composite of thromboembolic events (13.1% vs 15.5%, HR 0.83, 95% CI 0.72-0.96) compared with placebo, reported Barry Green...

Interesting Reads

COVID-19 News: Researchers Warn That SARS-CoV-2 Infections Can Lead To Splenic Infarctions!

Nikhil Prasad
Dec 14, 2023 4 months ago

BREAKING COVID-19 News! SARS-CoV-2 Affects Red Blood Cell Morphology!

Nikhil Prasad
Oct 04, 2023 7 months ago

Study Shockingly Shows That Many Exposed To The SARS-CoV-2 Omicron Variant Exhibit Hematuria And Proteinuria! Early Signs Of Possible Kidney Damage?

COVID-19-News-Omicron-Hematuria-Proteinuria-Kidney-Damage
May 30, 2023 11 months ago

Phenolic Phytochemicals From The Roselle Plant Or Hibiscus Sabdariffa (Thai: Krachiap กระเจี๊ยบ) Can Treat And Prevent Obesity

Herbs And Phytochemicals - Roselle - Obesity
Mar 08, 2023 1 year ago

COVID-19 News: Will SARS-CoV-2 Infections Ultimately Lead To An Increased Incidence Of Head And Neck Cancers?

COVID-19 News - Head And Neck Cancers - By Nikhil P & Kittisak M
Feb 02, 2023 1 year ago

Quercetin Emerging As One Of The Must Take COVID-19 Supplements Especially When Considering The Omicron Variant And Long COVID-19 Issues

Source: COVID-19 Supplements - Quercetin
Jan 02, 2022 2 years ago

COVID-19 News: Emerging Studies Shows SARS-CoV-2 Attacks The Digestive Tract Especially The Intestines Directly, Reported Case Of Bowel Perforation

Source: COVID-19 News
Sep 21, 2020 4 years ago

BREAKING! COVID-19 Symptoms: King’s College London and Massachusetts General Hospital Identify Six Specific Symptom Cluster ‘Types’ Of COVID-19 Infections.

Source: COVID-19 Symptoms
Jul 20, 2020 4 years ago

BREAKING NEWS! COVID-19 Alert: Research Led By Cedars-Sinai Indicates That Proton Pump Inhibitors (PPIs) Use Is Linked To Increased Risk Of COVID-19

Source: COVID-19 Alert
Jul 08, 2020 4 years ago

BREAKING NEWS! Study Of COVID-19 Recovered Patients In China Reveals That Lymphocytes Are Drastically Altered To Become Dysfunctional With Immunity Implications

Source: COVID-19 Recovered Patients
Jul 02, 2020 4 years ago

Occulus Hirsutus and AQCH: India Discreetly Developing And Testing COVID-19 Drug Based On Phytochemicals Extracted From Occulus Hirsutus Plant

Source: Occulus Hirsutus and AQCH
Jun 27, 2020 4 years ago

High-Flow Nasal Cannula: For COVID-19 Second Wave Preparations, Forget About Ventilators, Doctors Are Now Turning To High-Flow Nasal Cannula

Source: High-Flow Nasal Cannula
Jun 25, 2020 4 years ago

BREAKING! Androgens: Study Shows Bald Men Mostly Likely To Suffer Severe COVID-19 Conditions Due To High Levels Of Androgens

Source: Androgens And COVID-19
Jun 23, 2020 4 years ago

BREAKING! Hepatitis B: UAE COVID-19 Case Study Indicates That COVID-19 Could Induce Hepatitis B Virus Reactivation

Source: Hepatitis B and COVID-19
Jun 21, 2020 4 years ago

BREAKING! COVID-19 Research: Sodium Channels Could Be Affected As Coronavirus Spike Protein Has Similar Sequence To Human Epithelial Sodium Channel

Source: COVID-19 Research
Jun 21, 2020 4 years ago

BREAKING! Cannabis And COVID-19: Caflanone, A Flavonoid Extracted From A Distinct Cannabis Strain Could be A Therapeutic Drug Against the COVID-19

Source: Cannabis And COVID-19
Jun 20, 2020 4 years ago

Gargling: New Studies Show That Throat Gargling May Be Beneficial After All During COVID-19 Despite Being Labeled In the Past As Misinformation

Source: Gargling and COVID-19
Jun 19, 2020 4 years ago

BREAKING! COVID-19 Research: New Study Reveals That SARS-CoV-2 Coronavirus Also Affects Thyroid Functions In Majority Of COVID-19 Patients

Source: COVID-19 Research
Jun 17, 2020 4 years ago

Exploring Inhaled Nitric Oxide (iNo) As As An Adjuvant COVID-19 Treatment For Pulmonary Issues

Source: Nitric Oxide and COVID-19
Jun 15, 2020 4 years ago

Understanding The Differences Between COVID-19 Asymptomatic and Presymptomatic Conditions

Source: COVID-19 Asymptomatic and Presymptomatic
Jun 14, 2020 4 years ago

Researchers Say One Potential Long-Term Health Implication Of COVID-19 Could Be Hearing Loss

Source: COVID-19 Long-Term Health Implications
Jun 13, 2020 4 years ago

Scripp Institute Has Detected The Mutation That Most Scientist Dread: The D614G Mutation Which Could Make The SARS-CoV-2 More Infectious

Source: SARS-CoV-2 Mutations
Jun 13, 2020 4 years ago

BREAKING! Medical Experts Warn That COVID-19 Could Trigger Diabetes In Otherwise Healthy Individuals Who Never Had The Condition Before.

Source: Diabetes and COVID-19
Jun 13, 2020 4 years ago

Northwestern University Issues COVID-19 Warning That The Whole Nervous System Can Be Affected By The SARS-CoV-2 Coronavirus

Source: COVID-19 Warning
Jun 12, 2020 4 years ago

Acute Pancreatitis: Warning That Acute Pancreatitis Is Now Manifesting In COVID-19 Patients, A Condition Never Seen In Early Stages Of The Pandemic

Source: Acute Pancreatitis
Jun 11, 2020 4 years ago

Immune Health: Cistanche And Pu-erh Tea Supplements Could Help Improve Immune Factors And Reduce Pro-inflammatory Cytokines Such As Interleukin-6

Source: Immune Health
Jun 09, 2020 4 years ago

Study Finds That COVID-19 Also Causes Myocardial Injury (Heart Damage)

Source: Myocardial Injury
Jun 09, 2020 4 years ago

European COVID-19 Research Indicates That Individuals With Blood Group Type A Might Be More Vulnerable To Respiratory Failure

Source: COVID-19 Research
Jun 08, 2020 4 years ago

COVID-19 Research: Study From Columbia University Indicates That Lowering Testosterone Levels Could Reduce Severity Of COVID-19

Source: COVID-19 Research
Jun 08, 2020 4 years ago

Uric Acid: Japanese Researchers Discover That High Uric Acid Levels Protects Against Lung Function Decline Especially In Older Women

Source: Uric Acid Supplements
Jun 07, 2020 4 years ago

MUST READ! Strokes: Study Shows COVID-19 Increases Risk Of Strokes In Healthy Young Individuals. Global Increase In Stroke Deaths Last Few Months

Source: Strokes And COVID-19
Jun 05, 2020 4 years ago

BREAKING! Studies Show Famotidine, A Common Indigestion Drug Could Help In Mild To Moderate Cases Of COVID-19

Source: Famotidine And COVID-19
Jun 05, 2020 4 years ago

BREAKING! Pediatrics: Study Indicates That Multisystem Inflammatory Syndrome More Predominant Among Children Of African Ancestry Infected With COVID-19

Source: Pediatrics
Jun 04, 2020 4 years ago

Pregnancy And COVID-19: Study Shows Choline Supplements Could Help Pregnant Women Reduce Negative Effects Of COVID-19 In Newborns

Source: Pregnancy And COVID-19
Jun 02, 2020 4 years ago

COVID-19 Research: University Of Massachusetts Study Warns Of Emerging Genomic Variants In SARS-CoV-2 Coronavirus That Could Lead To Drug Resistance

Source: COVID-19 Research
May 29, 2020 4 years ago

Covid-19: New Study Published In JAMA Says Certain COVID-19 Recovered Patients Still Test Positive Even Days After Being Discharged

Source: Covid-19
May 29, 2020 4 years ago

BREAKING! Coronavirus Latest: Louisiana State University Pathologists’ First COVID-19 Autopsy Series Reveals Cardiopulmonary Anomalies

Source: Coronavirus Latest
May 28, 2020 4 years ago

MUST READ!!! Brazilian Respiratory Expert Says That COVID-19 Should Be Treated As A Thrombotic Disease

Source: COVID-19
May 28, 2020 4 years ago

COVID-19 Research: New Study Reveals That Specific Types Of T-Cells Are Targeted By The SARS-CoV-2 Coronavirus In Patient’s Immune System

Source: COVID-19 Research
May 27, 2020 4 years ago

COVID-19 Research: Could Disulfiram- A Drug To Prevent Alcoholism, Aid In Inhibiting Cytokine Storms In COVID-19?

Source: Covid-19 Research
May 26, 2020 4 years ago

BREAKING ALERT! COVID-19: Italian Researchers Discover Brain Lesions On COVID-19 Patients

Source: COVID-19
May 23, 2020 4 years ago

WARNING! COVID-19 Patients Could Also Develop Thyroid Infections

Source: COVID-19 News
May 21, 2020 4 years ago

COVID-19: Study Shows That COVID-19 Infections Could Lead To Delirium, PTSD and Other Psychiatric Disorders

Source: COVID-19 News
May 19, 2020 4 years ago

COVID-19 Supplements: Silymarin From Milk Thistle Could Perhaps Also Be Used As An Adjuvant Supplement To Help COVID-19 Patients

Source: COVID-19 Supplements
May 18, 2020 4 years ago

MUST READ! COVID-19 Supplements: Could Rutin Be The Secret Ingredient In China’s TCM Formulations That Helped Treat COVID-19 As Adjuvant Protocols?

Source: COVID-19 Supplements
May 15, 2020 4 years ago

COVID-19 Research: Worrying Gastrointestinal Abnormalities Revealed In Abdominal Imaging Studies Of COVID-19 Patients

Source: COVID-19 Research
May 12, 2020 4 years ago

COVID-19 Clinical Care: Kidney Failure Emerging As A Common Occurrence From COVID-19 Infections

Source: COVID-19 Clinical Care
May 12, 2020 4 years ago

MUST READ! COVID-19 Alerts: Children Are At High Risk For Critical Complications And Death From COVID-19

Source: COVID-19 Alerts
May 12, 2020 4 years ago

COVID-19 Therapeutics: Computational Screenings Show A Variety Of Natural Phytochemicals Could Have Efficacy Against SARS-CoV-2 Including EGCG From Green Tea

Source: COVID-10 Therapeutics
May 11, 2020 4 years ago

COVID-19 Drugs: Study Shows Common And Cheap Heartburn Drug Famotidine Improves Outcomes Of Hospitalized COVID-19 Patients

Source: COVID-19 Drugs
May 11, 2020 4 years ago

FROM COVID-19-GENETICS

LATEST ON MEDICAL NEWS (WORLD)

World COVID-19 News

COVID-19 Diagnostics

COVID-19 Drugs

COVID-19 Supplements

COVID-19 Herbs

COVID-19 Disinfectants

COVID-19 Mutations

COVID-19 Research

COVID News

Long COVID

COVID-19 Vaccines

COVID-19 Clinical Care

Medical Press Releases

Medical Innovations & Startups

AI in Medicine

Thailand Biotech News

Medical Spheres Bulletins

Medical White Papers

Medical Packages

Medical Tips

Medical Support Groups

MOST READ

Interesting Reads

FROM COVID-19-GENETICS

LATEST ON MEDICAL NEWS (WORLD)